Published on
January 10, 2020
- 16:00 GMT
Glancy Prongay & Murray Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Adamas Pharmaceuticals, Inc.
LOS ANGELES, Jan. 10, 2020 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming February 10, 2020 deadline to file a lead plaintiff motion in the class action filed on behalf of Adamas Pharmaceuticals, Inc. (“Adamas …
Distribution channels:
Consumer Goods, Law
...
